Arcturus Therapeutics Holdings Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Arcturus Therapeutics Holdings Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2019 to Q3 2024.
  • Arcturus Therapeutics Holdings Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $27.6M, a 6.56% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $27.6M -$1.94M -6.56% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $28.5M -$2.02M -6.61% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $29.4M -$2.14M -6.79% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $28.5M -$4.05M -12.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $29.5M -$3.99M -11.9% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $30.6M -$3.93M -11.4% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $31.6M +$26.3M +502% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $32.5M +$26.9M +479% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $33.5M +$27.5M +460% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $34.5M +$28.1M +444% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $5.25M -$1.45M -21.6% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $5.62M +$436K +8.41% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $5.98M +$1.12M +23.1% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $6.34M +$1.12M +21.5% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $6.69M +$1.12M +20.2% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $5.18M +$48K +0.94% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $4.86M -$462K -8.68% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $5.22M -$291K -5.28% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $5.57M Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $5.13M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $5.32M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $5.51M Jun 30, 2019 10-Q 2019-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.